首页 | 官方网站   微博 | 高级检索  
     


Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label,Phase-3b Study
Authors:Depei Wu  Xin Du  Jie Jin  Zhijian Xiao  Zhixiang Shen  Zonghong Shao  Xiao Li  Xiaojun Huang  Ting Liu  Li Yu  Jianyong Li  Baoan Chen  Guangsheng He  Zhen Cai  Hongchuang Liang  Jigang Li  Changgeng Ruan
Affiliation:1. The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People’s Republic of China
2. Guangdong General Hospital, Guangzhou, People’s Republic of China
3. The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, People’s Republic of China
4. Institute of Hematology and Blood Diseases Hospital, Tianjin, People’s Republic of China
5. Shanghai Jiaotong University Medical College Affiliated Ruijin Hospital, Shanghai, People’s Republic of China
6. Tianjin Medical University of General Hospital, Tianjin, People’s Republic of China
7. Shanghai 6th People’s Hospital, Shanghai, People’s Republic of China
8. Peking University People’s Hospital, Beijing, People’s Republic of China
9. West China Hospital of Sichuan University, Chengdu, People’s Republic of China
10. Chinese People’s Liberation Army General Hospital, Beijing, People’s Republic of China
11. Jiangsu Province Hospital/The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China
12. Zhongda Hospital Affiliated To Southeast University, Nanjing, People’s Republic of China
14. Xian-Janssen Pharmaceutical Ltd., Beijing, People’s Republic of China
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号